Innoviva
INVA
#5092
Rank
โ‚ฌ1.34 B
Marketcap
18,04ย โ‚ฌ
Share price
1.25%
Change (1 day)
-0.58%
Change (1 year)

Revenue for Innoviva (INVA)

Revenue in 2025 (TTM): โ‚ฌ0.34 Billion

According to Innoviva's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.33 Billion. In 2024 the company made a revenue of โ‚ฌ0.34 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ0.28 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Innoviva from 2005 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.34 B0.69%
2024 โ‚ฌ0.34 B22.74%
2023 โ‚ฌ0.28 B-9.08%
2022 โ‚ฌ0.30 B-10.73%
2021 โ‚ฌ0.34 B26.37%
2020 โ‚ฌ0.27 B17.52%
2019 โ‚ฌ0.23 B2.13%
2018 โ‚ฌ0.22 B26.03%
2017 โ‚ฌ0.18 B42.57%
2016 โ‚ฌ0.12 B157.36%
2015 โ‚ฌ49.34 M611.59%
2014 โ‚ฌ6.93 M102.49%
2013 โ‚ฌ3.42 M-96.66%
2012 โ‚ฌ0.10 B443.72%
2011 โ‚ฌ18.87 M3.65%
2010 โ‚ฌ18.21 M7.04%
2009 โ‚ฌ17.01 M2.98%
2008 โ‚ฌ16.52 M9.64%
2007 โ‚ฌ15.06 M1.51%
2006 โ‚ฌ14.84 M45.88%
2005 โ‚ฌ10.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
โ‚ฌ0.19 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚ฌ0.55 B 65.26%๐Ÿ‡บ๐Ÿ‡ธ USA